Sign In
30 Dec 2009 07:00
ο»Ώ
Deltex Medical Group plc
Grant of options
30 December 2009Β -Β Deltex Medical Group plc (the "Company"),Β the global leader in oesophageal Doppler monitoring ("ODM"), announces thatΒ the Board hasΒ yesterdayΒ approved the issue of share options to its executive members.
EMI scheme - Salary sacrifice
Following Ewan Phillips and Paul Mitchell's appointments as Chief Executive and Finance Director respectively,Β they have both elected to sacrifice the whole of the corresponding salary increases awarded by the Company's Remuneration Committee in respect of the period 3 September 2009 to 31Β December 2009, resulting in awards of options under theΒ Company's 2003 Enterprise Management IncentiveΒ Scheme as follows:Β
Β
|
Name |
Number |
Exercise Price Β£ |
Exercise periodΒ |
Total Number of EMI options held |
|
Β |
Β |
Β |
Β |
Β |
|
Ewan Phillips |
43,478 |
0.01 |
2009 - 2019 |
2,132,232 |
|
Β |
Β |
Β |
Β |
Β |
|
Paul Mitchell |
31,348 |
0.01 |
2009 - 2019 |
159,008 |
Β
Additional interests
Mr Phillips also has a beneficial interest inΒ 1,159,773Β ordinary sharesΒ in the Company representing 0.93Β per cent of the issued ordinary share capital of the Company.Β Mr Phillips also holds options over 2,480,000 shares in the Company's Employee share option scheme. These options have a range of exercise periods from 2012 to 2019.Β
MrΒ MitchellΒ also holds options over 615,000 shares in the Company's Employee share option scheme. These options have a range of exercise periods from 2012 to 2019.Β
All shares and options relate to ordinary 1p shares.
For further information, please contact:-
Deltex Medical Group plc 01243 774 837Nigel Keen, ChairmanΒ Ewan Phillips, Chief Executive Paul Mitchell, Finance Director
Nominated Adviser and Broker 0207 614 5917
Arden Partners plc
Christopher Hardie
Matthew Armitt
Follow the stocks
